Latest AI Articles:

This interview analysis is sponsored by Medable and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.Although there is seemingly a constant stream of impressive headlines touting new drug treatments or potential cancer cures, medical breakthroughs occur at a slow pace. It can take upwards of 10 years from the time a medical breakthrough is discovered until it is eventually available in the market.Clinical trials are necessary to test the safety and effectiveness of new treatments. When clinical trials fail before they even start, medical breakthroughs are obviously delayed. Fortunately, the emergence of AI has the potential to change that situation. 

Merck, a global leader in healthcare and pharmaceuticals, focuses on developing innovative medicines, vaccines, and animal health products to improve lives worldwide. 

This interview analysis is sponsored by OneTrust and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Over the past few years, global supply chains have faced rising complexity due to geopolitical shifts, trade barriers, and bottlenecks, which have increased the need for resiliency. In one of the recent podcasts with Emerj, Luke van der Waals, Demand-to-Deliver Value Stream Owner at SLB,  explained how these challenges are compounded by inflationary pressures, making it harder to manage margins and maintain operational efficiency. 

Generative AI (GenAI) adoption is accelerating across industries, with businesses aiming to enhance efficiency and drive revenue growth.

This interview analysis is sponsored by Interactions and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Over the past few years, global supply chains have faced rising complexity due to geopolitical shifts, trade barriers, and bottlenecks, which have increased the need for resiliency. In one of the recent podcasts with Emerj, Luke van der Waals, Demand-to-Deliver Value Stream Owner at SLB,  explained how these challenges are compounded by inflationary pressures, making it harder to manage margins and maintain operational efficiency. 

This interview analysis is sponsored by Arkestro and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

This interview analysis is sponsored by Interactions and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Kaiser Permanente (KP) is a leading managed care consortium based in Oakland, California. As of September 2024, KP has reported operating revenues of $85.4 billion and operating income of $1.2 billion. KP is pioneering and supporting AI advancements in healthcare by deploying cutting-edge technology to transform how medical organizations communicate, manage risks, and understand patient experiences.